Get started
Work

OFP01.03 Systemic and Intracranial Efficacy of Brigatinib vs.Crizotinib: Updated Results from the ALTA-1L Trial

Year: 2021
Type: conference-abstract
DOI: 10.1016/j.jtho.2020.10.035
Authors: S. Popat, H.R. Kim, M.-J. Ahn, James CH. Yang, J.-Y. Han, M. Hochmair, K.H. Lee, A. Delmonte, M.R. Garcia Campelo, D.-W. Kim, F. Griesinger, E. Felip, R. Califano, A. Spira, S. Gettinger, M. Tiseo, H. Lin, Y. Liu, P. Zhang, D.R. Camidge
Institutions: Royal Marsden Hospital, Yonsei University, Yonsei University Health System, Yonsei Cancer Hospital, Samsung Medical Center, National Taiwan University Hospital, National Cancer Center, Chungbuk National University, Chungbuk National University Hospital, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Complexo Hospitalario Universitario A Coruña, Seoul National University Hospital, Carl von Ossietzky Universität Oldenburg, Pius Hospital Oldenburg, Vall d'Hebron Hospital Universitari, University of Manchester, The Christie NHS Foundation Trust, Virginia Cancer Specialists, Yale Cancer Center, University of Parma, Takeda Oncology (United States), University of Colorado Cancer Center
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W3120469503
Cites:
Cited by:
Related to: 10